Comparison of Hematological Toxicity of mFOLFOX6 vs CAPOX Chemotherapy Regimens in Adjuvant Treatment of Stage II-III Colon Cancer Patients
2019; Elsevier BV; Volume: 19; Linguagem: Inglês
10.1016/j.clml.2019.07.192
ISSN2152-2650
AutoresLilit Harutyunyan, Jemma Arakelyan, Liana Safaryan, Armen Avagyan, Davit Zohrabyan, Lilit Sargsyan, Lusine Hakobyan, Samvel Iskanyan, Ruzanna Papyan, Martin Harutyunyan, Gohar Mkrtchyan, Marine Rushanyan, Gevorg Tamamyan, Samvel Danielyan, Aram Jilavyan, Armen Tananyan, Samvel Bardakhchyan,
Tópico(s)Colorectal and Anal Carcinomas
ResumoAdjuvant chemotherapy as part of the combination treatment in III stage and high-risk II stage colon cancer. Standard chemotherapy usually is based on Oxaliplatin and 5FU chemotherapy agents.
Referência(s)